NONALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NONALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NONALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise against silent liver disease
Disease control CompletedThis study tested whether the drug efinopegdutide could help adults with nonalcoholic steatohepatitis (NASH), a serious form of fatty liver disease. Researchers compared the drug against a placebo in 381 participants over 52 weeks to see if it could clear liver inflammation witho…
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Common vitamin tested to fight silent liver disease
Disease control CompletedThis study aimed to find the best dose of Vitamin E to help adults with nonalcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver. Researchers tested three different doses of Vitamin E against a placebo in 200 participants over 24 weeks. The main goal…
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC